UPDATED May 07, 2024
Potentially undervalued companies with a strong past performance and robust balance sheet.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
IVG | €11.55 | -2.2% | 45.0% | €3.1b | €15.66 | PE14x | E24.9% | 1.9% | ||
DAN | €33.55 | 3.5% | 41.9% | €2.2b | €39.00 | PE9.3x | E8.7% | 0.9% | ||
PVN | €11.85 | -2.1% | 13.4% | €605.8m | €15.40 | PE12.3x | E6.8% | 2.3% | ||
ESF | €4.30 | 5.4% | n/a | €82.8m | €4.95 | PE9.7x | E7.9% | n/a | ||
IRC | €2.19 | -1.8% | -8.8% | €58.0m | €3.00 | PE7x | E19.9% | 2.7% | ||
FVI | €16.60 | -3.5% | 7.8% | €42.2m | €24.80 | PE10.7x | E14.0% | 2.8% | ||
PAL | €5.80 | 1.8% | n/a | €37.6m | €12.00 | PE10.3x | E14.2% | n/a | ||
VIM | €1.37 | -2.1% | -4.2% | €18.4m | €2.73 | PE9.4x | E13.0% | 3.9% | ||
NUS | €0.95 | 4.4% | -31.7% | €17.6m | €3.40 | PE8x | E28.0% | n/a |